Novartis AG News Headlines

NVS 
$94.57
*  
2.28
2.47%
Get NVS Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Can This Supercomputer Partnership Unlock the Future of Healthcare?
9/13/2014 2:01:09 PM - Motley Fool


Vectura Group Following A Familiar Path
9/13/2014 8:44:00 AM - Seeking Alpha


Novartis LCZ696: 'New Wonder Drug' OR 'Old Paradigm With Reduced Side Effects'
9/12/2014 7:10:00 AM - Seeking Alpha


How Much Is Novartis's New Heart Failure Medicine Worth?
9/11/2014 4:56:00 PM - Seeking Alpha


Novartis Presents Data on Multiple Sclerosis Drug Gilenya - Analyst Blog
9/11/2014 4:55:00 PM - Zacks.com


In A Quiet Week, Affimed Therapeutics IPO Could Garner Investor Interest
9/11/2014 3:17:00 PM - Seeking Alpha


PDL BioPharma Sees Higher-than-Expected Revenues in Q3 - Analyst Blog
9/10/2014 5:40:00 PM - Zacks.com


$7.9B Non-Small Cell Lung Cancer Market: Just The Tip Of The Iceberg For Benitec's Tribetarna
9/10/2014 5:09:00 PM - Seeking Alpha


Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog
9/10/2014 3:45:00 PM - Zacks.com


Healthcare Industry Consolidation: The Rise Of Chinese M&A Funds
9/10/2014 8:23:00 AM - Seeking Alpha


Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 11, 2014
9/10/2014 8:00:02 AM - NASDAQ.com News


Novartis Bringing Forth A New Breakthrough Drug
9/8/2014 6:31:00 PM - Seeking Alpha


Achillion - An Options Strategy For A Potential Acquisition
9/8/2014 6:07:00 PM - Seeking Alpha


Is It Time to Buy Hospira, Inc.'s Stock?
9/8/2014 5:40:03 PM - Motley Fool


Novartis (NVS) Presents Positive Data on Ultibro Breezhaler - Analyst Blog
9/8/2014 4:05:00 PM - Zacks.com


Novartis Is Expanding Its Portfolio Effectively
9/8/2014 11:33:00 AM - Seeking Alpha


Novartis' LCZ696: A New Paradigm For Heart Failure Treatment
9/8/2014 10:11:00 AM - Seeking Alpha


3 Reasons Sanofi's Stock Could Fall
9/8/2014 6:30:02 AM - Motley Fool


Why Is Novartis Investing in This $49 Billion Market?
9/7/2014 5:03:02 PM - Motley Fool


ECB Decision Boosts ETFs
9/4/2014 3:02:03 PM - Benzinga


Open Your Eyes To Cooper Companies
9/4/2014 1:28:00 PM - Seeking Alpha


Teva Proves You Cannot Escape The Patent Cliff
9/4/2014 9:47:00 AM - Seeking Alpha


Novartis: The Rerating Has Further To Go
9/3/2014 2:08:00 PM - Seeking Alpha


Is It Time to Buy Amgen, Inc.'s Stock?
9/3/2014 8:01:02 AM - Motley Fool


Nature's Sunshine Products, Inc. (NATR) Ex-Dividend Date Scheduled for September 04, 2014
9/3/2014 8:00:01 AM - NASDAQ.com News